Pharmacy Legislative Day gives pharmacists, students, educators, professional associations, and patients an opportunity to discuss healthcare policy directly with legislators and legislative staff. The 2018 event described in this reflection was valuable because it transformed the legislative process from something studied in class into a professional activity that could be observed directly. I met pharmacy students from other schools, practicing pharmacists, institutional leaders, and Chris Hudtwalcker, who was representing the offices of Senator José Javier Rodríguez and Representative Evan Jenne. Those conversations made policy feel less distant and showed how healthcare professionals can contribute information that legislators may not encounter through statutes, budget documents, or committee reports alone.
The experience also clarified an important distinction between advocacy and lawmaking. Pharmacists, students, patients, associations, and other citizens can identify problems, propose solutions, provide evidence, and ask lawmakers to act. They do not themselves introduce a bill into the Florida Legislature unless they are serving in an authorized legislative role. The Florida Senate’s current public guidance explains that a legislator sponsors a bill, the bill is referred to committees, and both legislative chambers must ultimately agree on the measure before it can become law. Understanding this process makes advocacy more realistic because participants know where decisions actually occur and what information is useful at each stage (Florida Senate, 2026a).
Legislative Day Experience
Before attending the event, I viewed the legislative process as formal and somewhat inaccessible. Legislators seemed far removed from students, and I assumed that meaningful participation required senior professional status. The event changed that perception. Legislative advocacy depended less on prestige than on preparation. A student could introduce themselves, explain a healthcare problem, describe who was affected, and ask a clear question. The experience was therefore empowering, but it also demonstrated that access carries responsibility. A professional should not use a legislative meeting simply to advance private interests without explaining how a proposed change affects patients, cost, safety, access, or the broader healthcare system.
Meeting practicing pharmacists was especially useful because they connected legal language with everyday consequences. A statutory or regulatory provision can determine whether a pharmacist may provide a service, how a controlled substance is handled, whether an immunization can be administered, what documentation is required, or whether a patient can access a medication without delay. Practicing pharmacists were able to explain problems in operational terms and suggest language that might be workable in real settings.
Students from other pharmacy programs contributed another perspective. Their interests differed according to clinical goals, geographic setting, educational experience, and career plans. Some were more focused on community practice, others on hospital care, public health, business, research, or regulation. This diversity showed that “the pharmacy profession” is not one voice. Building a coalition requires finding a shared policy objective while recognizing that different sectors may experience the same proposed law differently.
The meeting with legislative staff was equally instructive. Staff members often research issues, prepare briefings, communicate with constituents, track bills, and help legislators understand technical subjects. Speaking with staff should not be viewed as secondary to speaking with an elected official. The Florida Senate’s current communication guidance specifically encourages citizens to contact legislators before action is taken, prepare concise factual material, focus on one issue, and offer supporting information. A well-prepared staff meeting can therefore become an important part of the legislative process (Florida Senate, 2026b).
The main negative aspect of the event was cost. Registration, travel, accommodation, missed work, and professional clothing can make attendance difficult for students or early-career practitioners. That barrier matters because advocacy should not be limited to people who can easily afford to travel to Tallahassee. Reduced student fees, scholarships, school funding, shared transportation, and virtual preparation sessions could broaden participation without changing the purpose of the event.
Advocacy Lessons
The event expanded my understanding of professional responsibility. A pharmacist’s role includes clinical judgment and safe medication use, but pharmacy practice is also shaped by law. Scope of practice, licensure, controlled substances, insurance, collaborative agreements, immunization authority, telehealth, patient privacy, reimbursement, and professional discipline all operate within a legal framework. Pharmacists therefore have information that can be useful when policy is written or amended.
Effective advocacy begins with a clearly defined problem. It is not enough to say that “pharmacy law should change.” Advocates should identify the specific barrier, who is affected, how frequently it occurs, what existing law contributes to it, and why current solutions are insufficient. A proposal should also consider who else may be affected. A change intended to help pharmacists can influence physicians, nurses, insurers, employers, patients, regulators, state budgets, or technology systems (National Alliance of State Pharmacy Associations, 2025).
Evidence strengthens credibility. A persuasive argument can include patient examples, but individual stories should be supported by broader data when possible. Advocates should understand the likely benefits, possible unintended effects, implementation cost, and objections. Legislators are more likely to trust professionals who acknowledge trade-offs than those who present every proposal as cost-free and universally beneficial.
Communication also needs to be concise. Florida Senate guidance recommends telling a legislator what effect an issue or bill may have, suggesting a course of action, using supporting facts, avoiding unnecessary jargon, and focusing on one issue at a time. For a pharmacy student, this means translating technical information into language that explains the patient or operational consequence without assuming that a legislator has clinical training (Florida Senate, 2026b).
Ethical advocacy requires transparency about professional interests. Pharmacy organizations may support policies that expand pharmacist services, reimbursement, or authority. Those proposals can still benefit patients, but advocates should explain the professional benefit openly and show how competence, documentation, referral, oversight, and quality will be maintained. Overstating shortages, cost savings, or clinical outcomes may help in one meeting but can damage long-term credibility (American Pharmacists Association, 2025).
Follow-up is part of advocacy as well. A short message thanking staff, answering a requested question, or supplying a one-page summary can be more valuable than repeating the original argument. Legislative staff manage many issues simultaneously, so accurate and easily retrievable information helps them return to the subject when the bill moves to another committee or stage.
From Idea to Law
In Florida, a policy idea becomes legislation only after a legislator decides to sponsor it. Citizens, healthcare professionals, associations, agencies, businesses, and advocacy groups can bring ideas forward, but the formal bill begins with legislative sponsorship. Drafting then converts the policy concept into statutory language that identifies which sections of Florida law would be created, amended, transferred, or repealed.
Once filed, the bill receives a number and is referred to one or more committees related to its subject matter. Committee review is a major decision point. Members can hear presentations, question the sponsor, consider staff analysis, receive public testimony, amend the bill, report it favorably, or decline to advance it. A proposal may therefore fail without ever receiving a vote of the full chamber. For advocates, this means that identifying the committees of reference is as important as identifying the original sponsor.
Healthcare proposals may also require fiscal and regulatory analysis. A bill may affect the Department of Health, Board of Pharmacy, Agency for Health Care Administration, Medicaid, state employee plans, information systems, licensing procedures, enforcement, or professional education. A policy that seems inexpensive at the practice level may require new state staff, databases, training, or rulemaking. Advocates should therefore consider implementation cost before claiming that a proposal will save money.
If a bill advances through committee, it can reach the full chamber for further consideration. The Florida Senate explains that after passage in one house, the measure is sent to the other house, where it goes through a similar process. The bill can move back and forth until both chambers agree on the same text, or it can fail at any stage. This is why passage in one chamber should never be described as final enactment (Florida Senate, 2026a).
When both houses approve identical legislation, the measure is enrolled and presented to the governor. Under the Florida Constitution, the governor can sign a bill, allow it to become law without signature under the applicable constitutional timing rules, or veto it (Fla. Const. art. III, §§ 7–8). A veto can be overridden only through the constitutionally required supermajority in both houses. The bill’s effective date may be specified in the legislation itself, so it is inaccurate to assume that every Florida law takes effect on the same date or a fixed number of days after adjournment.
Enactment can also be the beginning of another policy process. If the new law directs an agency or professional board to adopt rules, implementation will require further public work. Agencies may need to define forms, standards, reporting, enforcement, training, or technical requirements within the authority provided by the statute. Pharmacists can participate in this rulemaking stage because the practical effect of the law may depend heavily on how those details are written.
| Stage | Main Activity | Useful Professional Contribution |
|---|---|---|
| Problem definition | Identify a policy issue and affected population | Clinical examples, data, implementation barriers |
| Sponsorship and drafting | Legislator converts the idea into bill language | Technical review and stakeholder input |
| Committee review | Analysis, testimony, amendment, vote | Concise evidence and response to questions |
| Floor consideration | Debate, amendment, chamber vote | Clarify effects of current language |
| Second chamber | Similar committee and floor process | Continue education and coalition work |
| Governor | Signature, no-signature action, or veto | Implementation evidence and policy impact |
| Rulemaking and evaluation | Operational details and outcome monitoring | Practice feedback, quality data, correction of unintended effects |
Professional Reflection
The strongest lesson from Pharmacy Legislative Day was that policy participation is a learnable professional skill. Confidence did not come from already knowing every detail of government. It came from preparing the issue, listening carefully, asking questions, and understanding where additional information was needed. The event made legislation more understandable because I saw that laws emerge through many small interactions among legislators, staff, stakeholders, committees, agencies, and citizens.
The experience also changed the way I think about pharmacy leadership. A pharmacist can identify problems that are difficult to see from outside clinical practice: delays in obtaining medication, insurance barriers, unsafe prescribing patterns, shortages, duplication, or services that improve access but are not recognized in payment or law. Translating those observations into policy requires more than professional frustration. It requires evidence, drafting, stakeholder discussion, and willingness to revise the proposal when legitimate concerns emerge.
I also learned that legislative advocacy should continue after a bill passes. Supporters should ask whether the new policy actually improves the outcome it was designed to address. Measures may include patient access, medication safety, complaints, service use, cost, geographic availability, or unintended burden. A profession strengthens its credibility when it is willing to acknowledge that a favored policy needs modification.
The 2018 Legislative Day therefore affected both my civic understanding and my professional identity. It showed that pharmacists can contribute meaningfully to policymaking without becoming partisan advocates. Their most valuable role is to provide accurate clinical and operational knowledge, explain consequences, listen to competing views, and support policy that can be implemented safely. The event also revealed a participation problem: if cost keeps students and practitioners away, policymakers may hear from a narrower portion of the profession than they should.
Overall, Pharmacy Legislative Day transformed the lawmaking process from an abstract sequence into a professional responsibility I could understand. A policy idea does not move directly from a citizen to the governor. It requires a sponsor, formal drafting, committee review, chamber consideration, agreement between the House and Senate, gubernatorial action, and often agency implementation afterward. Knowing those stages makes future advocacy more precise because it connects the right message with the right decision point.
Works Cited
Florida Senate. (2026a). How an Idea Becomes a Law.
Florida Senate. (2026b). Effective Communication With a Legislator.
Florida Constitution, art. III, §§ 7–8.
American Pharmacists Association. (2025). Pharmacist Advocacy and Professional Engagement Resources.
National Alliance of State Pharmacy Associations. (2025). State Pharmacy Policy and Advocacy Resources.
Academic Master Education Team is a group of academic editors and subject specialists responsible for producing structured, research-backed essays across multiple disciplines. Each article is developed following Academic Master’s Editorial Policy and supported by credible academic references. The team ensures clarity, citation accuracy, and adherence to ethical academic writing standards
Content reviewed under Academic Master Editorial Policy.
